PET imaging more accurate in lung cancer staging

Positron emission tomography (PET) is a useful diagnostic tool that supports the need for more accurate staging of lung cancer and improved treatment for patients, concludes an extensive systematic review published online in Journal of National Cancer Institute.
The review conducted by the Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care led by a Sunnybrook researcher, Dr. Yee Ung, evaluates the accuracy and utility of 18-fluorodeoxyglucose PET (18FDG-PET) in the diagnosis and staging of lung cancer.
"Lung cancer remains the leading cause of cancer-related death and early diagnosis provides the best chance for long term survival," says Dr. Ung, chair, Lung Cancer Site Group, Odette Cancer Centre, Sunnybrook. "It is our hope this systematic review contributes to clinical guideline discussions exploring the potential of PET as part of standard preoperative work-up - along with computed tomography (CT) - to further enhance assessment of early-stage lung cancer."
While the standard imaging technologies CT provide structural information and defines disease states based on anatomical changes, PET provides complementary information on biochemical processes that may precede gross anatomical changes.
Key findings drawn from the literature review include PET imaging is accurate in differentiating between benign and malignant lung tumours as small as 1 centimetre. PET was also shown to be more effective for mediastinal (lymph nodes in the centre of the chest) staging in non-small cell lung cancer. Nonetheless, confirmation of PET findings by surgical biopsy remains important. With best available data, the researchers also identified good accuracy in staging extensive versus limited stage small cell lung cancer.
The Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care reviewed recent relevant health technology assessments, randomized trials and meta-analyses and also took into consideration studies evaluating the utility of PET.
"Future research is needed to determine not only if PET should be integrated into the standard staging and diagnostic processes of lung cancer but also how PET would be incorporated into the staging algorithm," says Ung.
In 2007, an estimated 23,300 Canadians will be diagnosed with lung cancer and 19,900 will die of it. The total number of lung cancer deaths (men and women combined) is greater than the number of either prostate or breast cancer related deaths combined. According to Lung Cancer Canada, in 2006, almost 23,000 Canadians were diagnosed with the disease and another 27,000 cases are expected to be diagnosed this year.
(Editor compiled and published
PET imaging more accurate in lung cancer staging at HealthNewsTrack on November 28, 2007 sourced from Sunnybrook Health Sciences Centre - http://www.sunnybrook.ca/news?id=500)
Lung Cancer - recent articles and current news stories:
-
Bevacizumab with chemotherapy provides no survival benefit for lung cancer patients-
Postoperative radiotherapy does not improve survival in lung cancer patients-
New lung cancer test could accurately guide treatment for people with lung cancer-
20% reduction in lung cancer mortality with low dose CT vs chest X ray-
Gene expression changes in nasal cells may help identify lung cancerMost related articles:
-
PET imaging more accurate in lung cancer staging-
Urine test predicts lung cancer risk in smokers - 6
-
New lung cancer test could accurately guide treatment for people with lung cancer - 5.4
-
Quitting smoking doubles survival in lung cancer patients - 5
-
Stem cell clue to lung cancer development - 4.8
More related articles:
- PET, Imaging, Lung cancer, Positron emission tomography, Cancer, Diagnosis, Tomography, Lung tumour, Biopsy
-
Quitting smoking doubles survival in lung cancer patients - 14.8
-
20% reduction in lung cancer mortality with low dose CT vs chest X ray - 12.3
-
Fir tree found in man's lung - 11.3
-
Gene expression changes in nasal cells may help identify lung cancer - 10.7
Lung Cancer related articles:
-
Quitting smoking doubles survival in lung cancer patients - 5
-
Urine test predicts lung cancer risk in smokers - 4.8
-
Lilly's lung cancer drug Alimta is approved in US - 4.8
-
Green tea may reduce lung cancer risk in smokers - 4.6
-
Fir tree found in man's lung - 4.5
Lung Cancer article/news source:
Read more health articles from
Sunnybrook Health Sciences Centre and
health articles from Canada.
Lung Cancer - search related terms:
Biopsy,
Cancer,
Diagnosis,
Imaging,
Lung cancer,
Lung tumour,
PET,
Positron emission tomography,
Tomography,
Lung Cancer books,
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Current news
For more accurate staging of lung cancer, PET imaging founds to be a useful diagnostic tool. Lung cancer remains the leading cause of cancer-related death and early accurate diagnosis provides improved treatment for patients and the best chance for long term survival.
What is Lung Cancer?About Lung Cancer -- Lung cancer is a disease in which the cells of the lung tissues grow uncontrollably and form tumors. There are two kinds of lung cancers, primary and secondary. Primary lung cancer (also called adenocarcinoma) starts in the lung itself. Primary lung cancer is divided into small cell lung cancer and non-small cell lung cancer, depending on how the cells look under the microscope. Secondary lung cancer is cancer that starts somewhere else in the body (for example, the breast or colon) and spreads to the lungs.